Literature DB >> 27822582

Are there any predictors of pyonephrosis in patients with renal calculus disease?

Madhusudan Patodia1, Apul Goel2, Vishwajeet Singh1, Bhupendra Pal Singh1, Rahul Janak Sinha1, Manoj Kumar1, Divakar Dalela1, Satya Narayan Sankhwar1.   

Abstract

The objective of the study is to identify factors predicting development of pyonephrosis in patients of renal calculus disease (RCD), as this knowledge is largely unknown. Patients of RCD without pyonephrosis (Group 1) or with pyonephrosis (Group 2) presenting between December 2013 and November 2015 were evaluated. All patients of RCD who had undergone either percutaneous nephrostomy (PCN) or surgical management (percutaneous nephrolithotomy/pyelolithotomy/nephrectomy) were included. Patients treated conservatively, by extracorporeal shock-wave lithotripsy and patients of bilateral RCD were excluded. Data regarding demography, co-morbidities, associated urologic disease, previous intervention, clinical presentation, urinary culture, renal function, grade of hydronephrosis, stone characteristics were collected. 501 patients were included (Group 1: 410; Group 2: 91). Mean age in years (35.02 versus 35.48), sex ratio (2.12:1 versus 2.25:1) and mean body mass index (kg/m2) (22.27 versus 22.15) were similar in both groups. Prevalence of diabetes mellitus (3.41% versus 3.29%, p = 1.000) was similar. Group 2 patients had longer duration of symptoms (5.77 versus 8.96 months, p < 0.0001), associated urological diseases such as ipsilateral PUJO and ureteric calculus (4.63% versus 12.08%, p = 0.0125), moderate/severe-grade hydronephrosis (49.75% versus 92.30%, p < 0.0001), presence of staghorn calculus (20.73% versus 62.63%, p < 0.0001), multiple calculi (48.29% versus 68.13% p = 0.0007) and nonfunctioning kidney (1.70% versus 71.42%, p < 0.0001) as predictors of pyonephrosis. In logistic multivariate analysis, additionally, past history of urological surgery (p = 0.044) was found associated with pyonephrosis. Our study identified some conditions associated with patients of pyonephrosis. To prove their role as risk factors we recommend further studies.

Entities:  

Keywords:  Infected hydronephrosis; Predictors of pyonephrosis; Pyonephrosis; Renal calculus disease; Renal stone; Staghorn calculi

Mesh:

Year:  2016        PMID: 27822582     DOI: 10.1007/s00240-016-0933-2

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  23 in total

1.  The diagnosis and immediate therapy of acute renal and perirenal infections.

Authors:  J N Corriere; C M Sandler
Journal:  Urol Clin North Am       Date:  1982-06       Impact factor: 2.241

2.  Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial.

Authors:  H Mokhmalji; P M Braun; F J Martinez Portillo; M Siegsmund; P Alken; K U Köhrmann
Journal:  J Urol       Date:  2001-04       Impact factor: 7.450

Review 3.  Urinary tract infection risk factors and gender.

Authors:  R D Harrington; T M Hooton
Journal:  J Gend Specif Med       Date:  2000 Nov-Dec

4.  [Pyonephrosis: diagnosis and treatment: report of 14 cases].

Authors:  R Rabii; A Joual; H Rais; H Fekak; K Moufid; S Bennani; M el Mrini; S Benjelloun
Journal:  Ann Urol (Paris)       Date:  2000-06

5.  Risk factors associated with acute pyelonephritis in healthy women.

Authors:  Delia Scholes; Thomas M Hooton; Pacita L Roberts; Kalpana Gupta; Ann E Stapleton; Walter E Stamm
Journal:  Ann Intern Med       Date:  2005-01-04       Impact factor: 25.391

6.  [Changes in kidney stones type according to sex and age in Tunisian patients].

Authors:  A Alaya; A Nouri; M Belgith; H Saad; I Hell; W Hellara; R Jouini; M F Najjar
Journal:  Actas Urol Esp       Date:  2011-12-16       Impact factor: 0.994

7.  Family history and risk of recurrent cystitis and pyelonephritis in women.

Authors:  Delia Scholes; Thomas R Hawn; Pacita L Roberts; Sue S Li; Ann E Stapleton; Lue-Ping Zhao; Walter E Stamm; Thomas M Hooton
Journal:  J Urol       Date:  2010-06-19       Impact factor: 7.450

8.  Sonography of pyonephrosis: a prospective study.

Authors:  B R Subramanyam; B N Raghavendra; M A Bosniak; R S Lefleur; R J Rosen; S C Horii
Journal:  AJR Am J Roentgenol       Date:  1983-05       Impact factor: 3.959

9.  Sensitivity of gray scale ultrasound in detecting urinary tract obstruction.

Authors:  P H Ellenbogen; F W Scheible; L B Talner; G R Leopold
Journal:  AJR Am J Roentgenol       Date:  1978-04       Impact factor: 3.959

10.  Associated risk factors of urinary tract infection among pregnant women at Felege Hiwot Referral Hospital, Bahir Dar, North West Ethiopia.

Authors:  Tazebew Emiru; Getenet Beyene; Wondewosen Tsegaye; Silabat Melaku
Journal:  BMC Res Notes       Date:  2013-07-25
View more
  5 in total

1.  Imaging of Group B Streptococcus infection in pyonephrosis: a case report.

Authors:  Ryan Elmanar; M Hidayat Surya Atmaja
Journal:  Radiol Case Rep       Date:  2022-07-10

2.  Machine learning-assisted decision-support models to better predict patients with calculous pyonephrosis.

Authors:  Hailang Liu; Xinguang Wang; Kun Tang; Ejun Peng; Ding Xia; Zhiqiang Chen
Journal:  Transl Androl Urol       Date:  2021-02

3.  Challenges and management of laparoscopic treatment of pyonephrosis caused by calculi.

Authors:  Jun Liu; Liang Chen; Lizhe An; Kai Ma; Xiongjun Ye; Qingquan Xu; Xiaobo Huang; Liulin Xiong
Journal:  BMC Surg       Date:  2020-12-10       Impact factor: 2.102

4.  High attenuation value in non-contrast computer tomography can predict pyonephrosis in patients with upper urinary tract stones.

Authors:  Xiaofei Lu; Dechao Hu; Benzheng Zhou
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

5.  Hounsfield unit attenuation value can differentiate pyonephrosis from hydronephrosis and predict septic complications in patients with obstructive uropathy.

Authors:  Luca Boeri; Irene Fulgheri; Franco Palmisano; Elena Lievore; Vito Lorusso; Francesco Ripa; Mario D'Amico; Matteo Giulio Spinelli; Andrea Salonia; Gianpaolo Carrafiello; Emanuele Montanari
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.